Clinical SNP-Array Adds Value to Diagnosis and Surveillance of Bone Marrow Failure Syndromes

Learn how clinical SNP-array technology enhances the diagnosis and surveillance of bone marrow failure syndromes in this 15-minute conference presentation by Lucilla Pizzo from the CGC 2024 Annual Meeting. Discover the clinical applications and diagnostic value that SNP-array analysis brings to identifying and monitoring bone marrow failure conditions. Explore how this genomic testing approach improves patient care by providing more accurate diagnoses and better surveillance capabilities for these complex hematological disorders. Gain insights into best practices for implementing SNP-array technology in clinical settings for bone marrow failure syndrome management, presented by experts in clinical cancer genomics and molecular pathology.